Skip to content

Fulgent Genetics, Inc. FLGT Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$75.01M-21.7%-$61.63M-39.5%-$44.17M+15.1%-$52.04M-24.3%-$41.87M+4.4%
$24.2M+0.3%$24.12M-0.3%$24.2M+0.5%$24.09M-0.4%$24.18M-3.0%
$38.92M-1.7%$39.58M-2.8%$40.71M-2.9%$41.92M-3.7%$43.51M-2.2%
-$25.09M-368%$9.36M-55.5%
$23.06M+2.1%$22.57M+5.6%$21.37M-38.7%$34.86M-14.9%$40.98M+1.6%
$0
$94.58M-15.1%$111.37M+53.1%$72.76M
-$48.45M-228%-$14.79M-1.4%-$14.58M+0.8%-$14.7M-11.3%-$13.21M-173%
-$43.88M-786%-$4.95M-108%$59.6M+160%$22.9M
-$118.23M+8.5%-$129.27M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Fulgent Genetics, Inc. generate?
Fulgent Genetics, Inc. (FLGT) generated -$105.6M in operating cash flow over the trailing twelve months.
What is Fulgent Genetics, Inc.'s free cash flow?
After $23.1M of capital expenditures, Fulgent Genetics, Inc.'s free cash flow was -$118.2M over the trailing twelve months, down 138.2% year over year.
Where does Fulgent Genetics, Inc.'s cash flow data come from?
Every line is extracted from Fulgent Genetics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.